Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless ...

Designed to rebalance the body’s immune response, the ASITI-201 drug can protect insulin-producing pancreatic cells. Study to determine if type 1 diabetes can be treated with osteoporosis medication ...

Each type requires a different approach to treatment. People with type 1 diabetes need to regularly administer insulin through injections or an insulin pump, while those with type 2 diabetes may ...

A Sanofi subsidiary has claimed FDA approval for the first biosimilar of Novo Nordisk's Novolog, an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart.

While the free version of the internet still holds sway, a new model has been quietly gaining in popularity, and the subscription based model is beginning to get real traction among fans, content ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Chip Stapleton is a Series 7 and Series 66 license holder, CFA Level 1 exam holder, and ...

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. David Kindness is a Certified Public Accountant (CPA) and an ...

In a big relief for Indian patients, Denmark-based Novo Nordisk said it is not discontinuing India’s largest-selling insulin brand, Human Mixtard. In recent weeks, concerns had been growing among ...

Go-Pen ApS announced recently that it received FDA 510(k) clearance for its Go-Pen cost-effective, user-filled insulin pen.